Journal of Nuclear Medicine: 58 (9)

September 1, 2017; Volume 58,Issue 9

Cover image

FEATURED ARTICLE

Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point ¹⁸F-FDG PET/CT Imaging in Patients with Advanced Melanoma. Steve Cho et al. See page 1421.

Can PET/CT predict response to immune checkpoint blockade in melanoma? James Kelly et al. See page 1442.

In this issue

Issue highlights

Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point ¹⁸F-FDG PET/CT Imaging in Patients with Advanced Melanoma
Dual-Target Binding Ligands with Modulated Pharmacokinetics for Endoradiotherapy of Prostate Cancer
Is Tau Imaging More Than Just Upside-Down ¹⁸F-FDG Imaging?
Operational and Dosimetric Aspects of Pediatric PET/CT

Initial Clinical Experience with ⁹⁰Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 Patients
Total-Body PET Multiparametric Imaging of Cancer Using a Voxelwise Strategy of Compartmental Modeling
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with ¹⁷⁷Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohort
Why We Did What We Did: PSMA PET/CT Selection Criteria for the VISION Trial
⁶⁸Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the ⁶⁸Ga-FAPI PET Prospective Observational Trial

More...

Main menu

User menu

Search

Table of Contents

Cover image

In this issue

Issue highlights

Jump to